About Chugai
Chugai's mission is to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- Dec 10, 2018 Establishment of "Gan with," an Information Website for Cancer Patients, Their Families and Coworkers
- Dec 07, 2018 Chugai Files for Additional Indication of Anti-PD-L1 Antibody TECENTRIQ® for Small Cell Lung Cancer
- Dec 06, 2018 Chugai Presents Interim Analysis Data of Phase I/II Study of SKY59, anti-C5 antibody in PNH at ASH
- Dec 06, 2018 Chugai Receives Orphan Drug Designation for TECENTRIQ® in Small cell Lung Cancer and for Entrectinib in NTRK Fusion-positive Solid Tumors
- Dec 05, 2018 Chugai Files Lawsuit against Alexion for Infringement of its Proprietary Antibody Engineering Technology in Japan
-
Diversity and Inclusion Initiatives
Find information on our initiatives to promote work-life balance and diverse human resources, and performance data for topics such as the ratio of female employees.
-
Engagement with Employees
Chugai promotes engagement with employees by conducting talent management according to each person's capabilities and aptitude, providing systems that help our diverse people to succeed, and creating supportive work environments.
